Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Deriglidole

Catalog No. T10998Cas No. 122830-14-2
Alias SL 86-0715

Deriglidole (SL 86-0715) is a peripheral adrenergic receptor antagonist that is a selective inhibitor of alpha2 receptors. Deriglidole inhibits colistin and Idazoxan but does not show activity against prazosin and rat cortical and human platelet α2-adrenergic receptors.

Deriglidole

Deriglidole

Purity: 99.45%
Catalog No. T10998Alias SL 86-0715Cas No. 122830-14-2
Deriglidole (SL 86-0715) is a peripheral adrenergic receptor antagonist that is a selective inhibitor of alpha2 receptors. Deriglidole inhibits colistin and Idazoxan but does not show activity against prazosin and rat cortical and human platelet α2-adrenergic receptors.
Pack SizePriceAvailabilityQuantity
1 mg$460In Stock
5 mg$1,060In Stock
10 mg$1,420In Stock
25 mg$2,100In Stock
50 mg$2,580In Stock
100 mg$3,400In Stock
1 mL x 10 mM (in DMSO)$792In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Deriglidole"

Select Batch
Purity:99.45%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Deriglidole (SL 86-0715) is a peripheral adrenergic receptor antagonist that is a selective inhibitor of alpha2 receptors. Deriglidole inhibits colistin and Idazoxan but does not show activity against prazosin and rat cortical and human platelet α2-adrenergic receptors.
In vitro
Deriglidole is a specific inhibitor of α2-receptors. Deriglidole inhibits the binding of [3H] clonidine and [3H] imidazole x, while showing no inhibitory effect on the binding of [3H] prazosin to rat cortex and human platelet α2-adrenergic receptors. Furthermore, it demonstrates greater effectiveness than idazolide in selectively targeting peripheral receptors.[1]
In vivo
In mouse pancreatic beta-cells that both deriglidole and SL86.0714 inhibit ATP-sensitive K+ channel with similar potency whereas alpha2-adrenoceptors are blocked only by deriglidole. In diabetic rats, SL84.0418 and deriglidole (10 mg/kg i.p.) fully normalized glucose tolerance whereas SL86.0714 and tolbutamide only slightly improved it. Five min after deriglidole administration in mice a marked and short lasting rise in insulin levels was observed, followed by a progressive reduction of glycemia.[2]
AliasSL 86-0715
Chemical Properties
Molecular Weight255.36
FormulaC16H21N3
Cas No.122830-14-2
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 32.5 mg/mL (127.27 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.9160 mL19.5802 mL39.1604 mL195.8020 mL
5 mM0.7832 mL3.9160 mL7.8321 mL39.1604 mL
10 mM0.3916 mL1.9580 mL3.9160 mL19.5802 mL
20 mM0.1958 mL0.9790 mL1.9580 mL9.7901 mL
50 mM0.0783 mL0.3916 mL0.7832 mL3.9160 mL
100 mM0.0392 mL0.1958 mL0.3916 mL1.9580 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Deriglidole | purchase Deriglidole | Deriglidole cost | order Deriglidole | Deriglidole chemical structure | Deriglidole in vivo | Deriglidole in vitro | Deriglidole formula | Deriglidole molecular weight